These findings highlight the role of natural 5-LOX inhibitors, such as those found in W. ugandensis, as a novel therapeutic approach for preventing or treating CRC, reinforcing the idea that W. ugandensis extracts may provide a promising alternative to conventional therapies for managing inflammation-driven cancers like CRC. The gene discussed is ALOX5; the disease is colorectal carcinoma.